172 related articles for article (PubMed ID: 21904818)
1. LOX-1/LOXIN: the yin/yang of atheroscleorosis.
Mango R; Predazzi IM; Romeo F; Novelli G
Cardiovasc Drugs Ther; 2011 Oct; 25(5):489-94. PubMed ID: 21904818
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction.
Mango R; Biocca S; del Vecchio F; Clementi F; Sangiuolo F; Amati F; Filareto A; Grelli S; Spitalieri P; Filesi I; Favalli C; Lauro R; Mehta JL; Romeo F; Novelli G
Circ Res; 2005 Jul; 97(2):152-8. PubMed ID: 15976314
[TBL] [Abstract][Full Text] [Related]
3. The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization.
Biocca S; Filesi I; Mango R; Maggiore L; Baldini F; Vecchione L; Viola A; Citro G; Federici G; Romeo F; Novelli G
J Mol Cell Cardiol; 2008 Mar; 44(3):561-70. PubMed ID: 18191942
[TBL] [Abstract][Full Text] [Related]
4. Genotyping OLR1 gene: a genomic biomarker for cardiovascular diseases.
Vecchione L; Gargiul E; Borgiani P; Predazzi I; Mango R; Romeo F; Magnani M; Novelli G
Recent Pat Cardiovasc Drug Discov; 2007 Jun; 2(2):147-51. PubMed ID: 18221114
[TBL] [Abstract][Full Text] [Related]
5. LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies.
Rizzacasa B; Morini E; Pucci S; Murdocca M; Novelli G; Amati F
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146073
[TBL] [Abstract][Full Text] [Related]
6. Effect of IL-10 on LOX-1 expression, signalling and functional activity: an atheroprotective response.
Arjuman A; Chandra NC
Diab Vasc Dis Res; 2013 Sep; 10(5):442-51. PubMed ID: 23811604
[TBL] [Abstract][Full Text] [Related]
7. Loxin Reduced the Inflammatory Response in the Liver and the Aortic Fatty Streak Formation in Mice Fed with a High-Fat Diet.
Reyes C; Nova-Lamperti E; Duran-Sandoval D; Rojas D; Gajardo J; Guzman-Gutierrez E; Bustos-Ruiz C; Ormazábal V; Zúñiga FA; Escudero C; Aguayo C
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806336
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of LOXIN Protects Endothelial Progenitor Cells From Apoptosis Induced by Oxidized Low Density Lipoprotein.
Veas C; Jara C; Willis ND; Pérez-Contreras K; Gutierrez N; Toledo J; Fernandez P; Radojkovic C; Zuñiga FA; Escudero C; Aguayo C
J Cardiovasc Pharmacol; 2016 Apr; 67(4):326-35. PubMed ID: 26771151
[TBL] [Abstract][Full Text] [Related]
9. LOX-1 variants modulate the severity of cardiovascular disease: state of the art and future directions.
Lubrano V; Balzan S; Papa A
Mol Cell Biochem; 2023 Oct; ():. PubMed ID: 37789136
[TBL] [Abstract][Full Text] [Related]
10. LOX-1 and obesity.
Yan M; Mehta JL; Hu C
Cardiovasc Drugs Ther; 2011 Oct; 25(5):469-76. PubMed ID: 21881850
[TBL] [Abstract][Full Text] [Related]
11. Oxidized LDL, LOX-1 and atherosclerosis.
Mitra S; Goyal T; Mehta JL
Cardiovasc Drugs Ther; 2011 Oct; 25(5):419-29. PubMed ID: 21947818
[TBL] [Abstract][Full Text] [Related]
12. IVS4-14 A/G and IVS4-73 C/T polymorphisms in OLR1 gene in patients with ischemic cerebrovascular diseases.
Vietri MT; Molinari AM; Boggia M; Parisi M; Cioffi M
Genet Test Mol Biomarkers; 2010 Feb; 14(1):9-11. PubMed ID: 19929426
[TBL] [Abstract][Full Text] [Related]
13. OLR1 and Loxin Expression in PBMCs of Women with a History of Unexplained Recurrent Miscarriage: A Pilot Study.
Bruno V; Rizzacasa B; Pietropolli A; Capogna MV; Massoud R; Ticconi C; Piccione E; Cortese C; Novelli G; Amati F
Genet Test Mol Biomarkers; 2017 Jun; 21(6):363-372. PubMed ID: 28409654
[TBL] [Abstract][Full Text] [Related]
14. LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis.
Chistiakov DA; Orekhov AN; Bobryshev YV
Cell Physiol Biochem; 2016; 38(5):1851-9. PubMed ID: 27160316
[TBL] [Abstract][Full Text] [Related]
15. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
[TBL] [Abstract][Full Text] [Related]
16. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.
Reiss AB; Anwar K; Wirkowski P
Curr Med Chem; 2009; 16(21):2641-52. PubMed ID: 19601801
[TBL] [Abstract][Full Text] [Related]
17. Role of six single nucleotide polymorphisms, risk factors in coronary disease, in OLR1 alternative splicing.
Tejedor JR; Tilgner H; Iannone C; Guigó R; Valcárcel J
RNA; 2015 Jun; 21(6):1187-202. PubMed ID: 25904137
[TBL] [Abstract][Full Text] [Related]
18. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis].
Morawietz H
Dtsch Med Wochenschr; 2010 Feb; 135(7):308-12. PubMed ID: 20146162
[TBL] [Abstract][Full Text] [Related]
19. Lectin-like Oxidized Low-Density Lipoprotein (LDL) Receptor (LOX-1): A Chameleon Receptor for Oxidized LDL.
Zeya B; Arjuman A; Chandra NC
Biochemistry; 2016 Aug; 55(32):4437-44. PubMed ID: 27419271
[TBL] [Abstract][Full Text] [Related]
20. LOX-1: a critical player in the genesis and progression of myocardial ischemia.
Lü J; Mehta JL
Cardiovasc Drugs Ther; 2011 Oct; 25(5):431-40. PubMed ID: 21847544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
